With 2.17 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.77 million shares. During the session, the Medical Care Facilities company that operates in wider Healthcare sector, reached to the highest price of $2.26 whereas the lowest price it dropped to was $2.05. The 52-week range on TOI shows that it touched its highest point at $3.50 and its lowest point at $0.13 during that stretch. It currently has a 1-year price target of $7.00. Beta for the stock currently stands at 0.04.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of TOI was down-trending over the past week, with a drop of -6.38%, but this was down by -31.03% over a month. Three-month performance surged to 92.98% while six-month performance rose 727.38%. The stock gained 611.97% in the past year, while it has gained 389.98% so far this year. A look at the trailing 12-month EPS for TOI yields -0.70 with Next year EPS estimates of -0.09. For the next quarter, that number is -0.09. This implies an EPS growth rate of 46.48% for this year and 76.32% for next year.
Float and Shares Shorts:
At present, 88.93 million TOI shares are outstanding with a float of 45.65 million shares on hand for trading. On 2025-06-13, short shares totaled 2.41 million, which was 261.99998 higher than short shares on 1747267200. In addition to Mr. Richard Alan Barasch as the firm’s Chairman of the Board, Dr. Daniel Virnich FACHE, M.B.A., M.D. serves as its CEO & Executive Director.
Institutional Ownership:
Through their ownership of 0.3463 of TOI’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2025-03-31, TOI reported revenue of $104406000.0 and operating income of -$9911000.0. The EBITDA in the recently reported quarter was -$8879000.0 and diluted EPS was -$0.21.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for TOI since 2 analysts follow the stock currently. There are 2 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With TOI analysts setting a high price target of 7.0 and a low target of 7.0, the average target price over the next 12 months is 7.0. Based on these targets, TOI could surge 218.18% to reach the target high and rise by 218.18% to reach the target low. Reaching the average price target will result in a growth of 218.18% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.36 being high and -$0.36 being low. For TOI, this leads to a yearly average estimate of -$0.36. Based on analyst estimates, the high estimate for the next quarter is $0 and the low estimate is $0. The average estimate for the next quarter is thus $0.
